A clinical trial to study the pain relieving effect of two different doses of buprenorphine patch in post-operative pain relief in patients undergoing laparoscopic surgeries under general anaesthesia
Not Applicable
- Conditions
- Health Condition 1: K35-K38- Diseases of appendixHealth Condition 2: N00-N99- Diseases of the genitourinary systemHealth Condition 3: K80-K87- Disorders of gallbladder, biliary tract and pancreasHealth Condition 4: K40-K46- HerniaHealth Condition 5: O- Medical and SurgicalHealth Condition 6: 1- ObstetricsHealth Condition 7: O00-O9A- Pregnancy, childbirth and the puerperium
- Registration Number
- CTRI/2023/05/052229
- Lead Sponsor
- ESIC MEDICAL AND HOSPITA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA physical status I, II
Patients posted for laparoscopic surgeries under GA
Exclusion Criteria
•Patient refusal
•Patients with skin allergy
•Patients with severe hepatic and renal dysfunction
•Pregnant and lactating women
•Bleeding disorders
•Respiratory diseases such as chronic obstructive pulmonary disease, bronchial asthma
•Hypersensitivity to study drug
•Epileptic patients
•ASA III ,IV
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain-free duration measured using VAS scaleTimepoint: From the time of extubation upto 48 hours <br/ ><br>
- Secondary Outcome Measures
Name Time Method The amount of analgesics required over 48 hrs. <br/ ><br> <br/ ><br>Variation in heart rate, NIBP, MAP intra- operatively. <br/ ><br> <br/ ><br>Level of sedation using Ramsay sedation scale <br/ ><br>Timepoint: serially upto 48 hours